Detalhe da pesquisa
1.
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.
J Hepatol;
58(6): 1104-12, 2013 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23395690
2.
Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys® Immunoassay in the S Protein Vaccination Era.
Viruses;
15(4)2023 04 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37112910
3.
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.
Clin Infect Dis;
55(5): 728-36, 2012 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22610932
4.
Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.
J Antimicrob Chemother;
67(10): 2479-86, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22729925
5.
Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen.
J Antimicrob Chemother;
67(6): 1453-8, 2012 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22378681
6.
Antibody Response Induced by BNT162b2 and mRNA-1273 Vaccines against the SARS-CoV-2 in a Cohort of Healthcare Workers.
Viruses;
14(6)2022 06 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35746706
7.
Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.
Clin Infect Dis;
48(8): 1152-9, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19275492
8.
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.
J Antimicrob Chemother;
62(4): 793-6, 2008 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18567911
9.
Chest wall abscess. / Absceso de pared torácica.
Enferm Infecc Microbiol Clin (Engl Ed);
38(9): 446-447, 2020 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-32299724
10.
Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients.
AIDS;
29(8): 977-9, 2015 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25784438
11.
Switch strategies in antiretroviral therapy regimens.
Expert Rev Anti Infect Ther;
12(9): 1055-74, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25075752
12.
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study.
J Int AIDS Soc;
17(4 Suppl 3): 19814, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25397558
13.
Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.
Am J Trop Med Hyg;
88(6): 1196-202, 2013 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23509119
14.
Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children.
J Acquir Immune Defic Syndr;
59(1): 31-8, 2012 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22156821
15.
Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system.
Antivir Ther;
16(6): 887-93, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21900721
16.
Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients.
AIDS;
24(7): 975-82, 2010 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20299963
17.
Acute renal failure and liver toxicity in an HIV/hepatitis C coinfected patient receiving telaprevir and boosted atazanavir.
AIDS;
28(10): 1538-9, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24896804